European Pharmaceutical Review

APRIL 18, 2023

billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

European Pharmaceutical Review

NOVEMBER 29, 2023

This step is important as these countries are key markets for pharmaceuticals manufacturing. Based on data on sales/value-based shares from various companies for APIs and Chemicals, India and China are estimated to account for up to half of materials for medicines, the Sustainable Markets Initiative (SMI) noted.

Manufacturing 107

Manufacturing Marketing Pharma Pharmaceutical manufacturing 107

European Pharmaceutical Review

NOVEMBER 9, 2023

This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

NOVEMBER 10, 2023

Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Manufacturing 97

Manufacturing Medicine Management Pharmaceutical 97

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

Pharmaceutical Technology

FEBRUARY 27, 2025

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

Manufacturing 66

Manufacturing Pharmaceutical manufacturing Medicine Pharma 66

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8

Pharma 130

Pharma Pharmaceutical manufacturing Manufacturing Pharmaceutical 130

PharmaTech

AUGUST 15, 2022

What actions can we as manufacturers take to make a difference to sustainability without disrupting the supply of our life-saving medicines?

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 52

European Pharmaceutical Review

JANUARY 16, 2023

A Mutual Recognition Agreement (MRA) relating to pharmaceutical Good Manufacturing Practice (GMP) has been signed between Switzerland and the US. Good Manufacturing Practice for pharmaceutical drugs. The FDA already has a MRA in place with the European Union (EU) and one with the UK.

Food and Drug Administration 122

Food and Drug Administration FDA Manufacturing Food 122

European Pharmaceutical Review

MAY 23, 2024

A paper has reported a multi-material ink-jet 3D printing (MM-IJ3DP)-based method that could enable tailored drug release profiles of personalised pharmaceutical tablets during manufacturing. Rivers et al. This paper features in the June 2024 issue of the journal Materials Today Advanced.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Medicine Pharmaceutical 98

European Pharmaceutical Review

JULY 25, 2022

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

European Pharmaceutical Review

SEPTEMBER 14, 2023

The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site. This increases renewable energy capacity to the national gas grid.

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

OCTOBER 6, 2023

The Indian Pharmacopoeia Commission (IPC) is now a member the Pharmacopoeial Discussion Group (PDG). Thus, a key aim for the PDG is to harmonise select pharmacopoeial standards.

Medicine 105

Medicine Pharmaceutical manufacturing Manufacturing Pharmaceutical 105

European Pharmaceutical Review

NOVEMBER 24, 2023

billion (16 billion Danish kroner) to expand its production site in Chartres, France, supporting manufacture of its products for serious chronic diseases. Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

Pharmaceutical Technology

APRIL 18, 2023

Eli Lilly and Company (Lilly) has unveiled plans to invest $1.6bn in its two new manufacturing facilities located within the LEAP Innovation Park in Boone County, Indiana, US. The investment at the LEAP site marks the company’s biggest manufacturing investment at a single location to date.

Manufacturing 52

Manufacturing Food and Drug Administration Pharmaceutical manufacturing Medicine 52

World of DTC Marketing

DECEMBER 10, 2020

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. Raymond Gilmartin, a former Merck CEO, once said to The Wa ll Street Journal: “The price of medicines is not determined by their research costs.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

European Pharmaceutical Review

AUGUST 25, 2023

The European Commission (EC)’s revised Annex 1 – Manufacture of Sterile Medicinal Products is now effective in the EU. As of 25 August 2023, pharmaceutical manufacturers are required to implement the GMP regulation into cleaning and bio-decontamination procedures for these products.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Training 98

European Pharmaceutical Review

SEPTEMBER 26, 2022

AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

DECEMBER 18, 2023

Additionally, in October, EPR shared Phase III trial data for the type 1 diabetes treatment TZIELD (Teplizumab), which suggested that the medicine could slow disease progression. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. This is despite these sites represented only 30 percent of FY2022 inspections.

Food and Drug Administration 105

Food and Drug Administration FDA Manufacturing Product sample 105

PM360

AUGUST 26, 2024

Now, precision medicine needs an overhaul. During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. How can a newly expanded definition of precision medicine help? Today, they have implemented the precision medicine approach across 90% of their portfolio.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

European Pharmaceutical Review

MAY 1, 2024

Our Ludwigshafen site serves as a centre of excellence for both research and development and pharmaceutical manufacturing and will play a critical role in AbbVie’s future growth,” stated Azita Saleki-Gerhardt , PhD, Executive Vice President, Chief Operations Officer. The new R&D building in Germany is expected to completed in 2027.

Pharmaceutical manufacturing 98

Pharmaceutical manufacturing Medicine Pharmaceutical Patients 98

Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

European Pharmaceutical Review

APRIL 18, 2024

Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). Wastewater samples taken at or close to the point of generation in manufacturing typically have a much higher API concentration, thus require less analytical sensitivity.

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

European Pharmaceutical Review

MARCH 13, 2024

In the paper, the author acknowledged that topical medicinal products require the absence of bacterial species such as P. Conclusion Overall, the method facilitates the “timely monitoring of pharmaceutical preparations and resources to limit contamination throughout the pharmaceutical manufacturing process,” the author asserted.

Media 98

Media Medical Pharmaceutical manufacturing Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 12, 2023

In recent years, nitrosamines have been detected in various medicines, leading to voluntary product recalls from the market. Nitrosamines analysis is, thus, key to ensuring safety and quality in the pharmaceutical industry.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Safety Pharmaceutical Manufacturing 59

European Pharmaceutical Review

FEBRUARY 9, 2023

Processes in pharmaceutical manufacturing such as processing, milling, grinding, and mixing, are associated with the generation of dust. The researchers highlighted that the risks of hazard exposure include danger to the health of operators and cross-contaminations during manufacturing.

Transportation 105

Transportation Specialization Distribution Manufacturing 105

European Pharmaceutical Review

JULY 24, 2024

BeiGene has opened its flagship US manufacturing facility in Hopewell, New Jersey. Addition of our facility at the Princeton West Innovation Campus adds manufacturing and clinical development capabilities…to advance quality medicines faster for patients,” commented John Oyler , Co-Founder, Chairman and CEO of BeiGene.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Medicine Pharmaceutical 52

European Pharmaceutical Review

AUGUST 29, 2024

The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme is a joint initiative between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI). Importantly, NHS patients will be able to access new treatments earlier.

Government 59

Government Pharma Competition Medicine 59

pharmaphorum

NOVEMBER 1, 2022

The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on life sciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.

Manufacturing 52

Manufacturing Biopharma Medicine Pharmaceutical manufacturing 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Discover the top pharmaceutical wholesalers. Worldwide sourcing and drop-ship of orphan medicines, and.

Leads 52

Leads Pharmaceutical Customer Relationship Management Retail 52

European Pharmaceutical Review

FEBRUARY 10, 2025

AstraZeneca has scrapped its planned 450 million expansion of a vaccine manufacturing facility in Liverpool, UK, citing economic factors and reduced government funding. AstraZeneca remains committed to its UK operations but continues to assess opportunities in regions that offer more favourable financial conditions and regulatory support.

Government 52

Government Manufacturing Competition Pharmaceutical manufacturing 52

European Pharmaceutical Review

OCTOBER 3, 2024

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Pharmaceutical Education 52

Contrarian Sales Techniques

FEBRUARY 26, 2023

There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. The market for medicines in Malaysia is divided between private clinics, private clinics, and pharmacies.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97